NLRP3 and Parkinson disease: They concluded that the extract exerts neuroprotective effects on 6-OHDA-induced dyskinesia and dopaminergic neuron degeneration in PD mice, as well as reduces the secretion of inflammatory factors via attenuation of microglial NLRP3 inflammasome activation, suggesting that SAFE could be a potential drug for PD treatment.